Arcturus Therapeutics Holdings Inc.
ARCT
$6.72
$0.172.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -65.78M | -66.71M | -60.16M | -68.20M | -80.94M |
| Total Depreciation and Amortization | 3.03M | 3.16M | 3.31M | 3.44M | 3.54M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 27.69M | 27.72M | 31.52M | 35.00M | 38.46M |
| Change in Net Operating Assets | -39.20M | -22.50M | -39.61M | -59.57M | -20.81M |
| Cash from Operations | -74.27M | -58.33M | -64.94M | -89.33M | -59.75M |
| Capital Expenditure | -230.00K | -318.00K | -217.00K | -545.00K | -648.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -230.00K | -318.00K | -217.00K | -545.00K | -648.00K |
| Total Debt Issued | 15.00M | 15.00M | 15.00M | 15.00M | -- |
| Total Debt Repaid | -15.00M | -15.00M | -15.00M | -- | -- |
| Issuance of Common Stock | 13.38M | 1.83M | 1.30M | 3.43M | 5.42M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.38M | 1.83M | 1.30M | 18.43M | 5.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.12M | -56.82M | -63.86M | -71.45M | -54.98M |